Dynavax
+$0.47 (+6.41%) Today
-$0.05 (-0.64%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Dynavax and other stocks, options, and ETFs commission-free!
About DVAX
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
CEO
Ryan Spencer
Employees
245
Headquarters
Emeryville, California
Founded
1996
DVAX Key Statistics
Market Cap
916.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.43M
High Today
$7.87
Low Today
$7.37
Open Price
$7.40
Volume
3.41M
52 Week High
$12.44
52 Week Low
$3.58
DVAX Earnings
-$0.53
-$0.35
-$0.17
$0.01
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.02 per share
Actual
$0.01 per share